Premium
O2–11–02: PET radioligand binding to translocator protein may mark conversion from mild cognitive impairment to Alzheimer's disease
Author(s) -
Kreisl William,
Lyoo Chul Hyoung,
McGwier Meghan,
Snow Joseph,
Jenko Kimberly,
Kimura Nobuyo,
Corona Winston,
Morse Cheryl,
Zoghbi Sami,
Pike Victor,
McMahon Francis,
Turner Raymond,
Innis Robert
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.04.196
Subject(s) - translocator protein , radioligand , precuneus , positron emission tomography , psychology , neuroinflammation , medicine , alzheimer's disease , biomarker , neuroscience , pathology , inflammation , disease , cognition , receptor , biology , biochemistry
O2-11-02 PET RADIOLIGAND BINDING TO TRANSLOCATOR PROTEIN MAY MARK CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE William Kreisl, Chul Hyoung Lyoo, Meghan McGwier, Joseph Snow, Kimberly Jenko, Nobuyo Kimura, Winston Corona, Cheryl Morse, Sami Zoghbi, Victor Pike, Francis McMahon, Raymond Turner, Robert Innis THE FOUNDATION FOR NIH BIOMARKERS CONSORTIUM PET RADIOLIGAND PROJECT TEAM,National Institute of Mental Health, Bethesda, Maryland, United States; Georgetown University, Washington, D.C. United States; Foundation for the National Institutes of Health, Bethesda, Maryland, United States. Contact e-mail: kreislw@mail.nih.gov